HLHan-Ying Lin

Han-Ying Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Han-Ying Lin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Liu

    Provincial Key Laboratory of Natural Drug Pharmacology, Department of Pharmacy, Fujian Medical University, Fuzhou 350122, China

    1 shared publication
  • Fan Cao

    Provincial Key Laboratory of Natural Drug Pharmacology, Department of Pharmacy, Fujian Medical University, Fuzhou 350122, China

    1 shared publication
  • Jing Chen

    Provincial Key Laboratory of Natural Drug Pharmacology, Department of Pharmacy, Fujian Medical University, Fuzhou 350122, China

    1 shared publication
  • Xinhua Ma

    Faculty of Pharmacy, Fujian Medical University, Fuzhou 350122, China

    1 shared publication
  • Yong-Hong Zhang

    Key Laboratory of Natural Drug Pharmacology in Fujian Province, School of Pharmacy, Fujian Medical University, 88 Jiao Tong Road, Fuzhou, 350004, P. R. China

    1 shared publication
  • Zhen-Wei Chen

    Provincial Key Laboratory of Natural Drug Pharmacology, Department of Pharmacy, Fujian Medical University, Fuzhou 350122, China

    1 shared publication

Latest Publications

  • Open Access

    Chemical Constituents from the Fruit of Melia azedarach and Their Anti-Inflammatory Activity

    by Fan Cao, Jing Chen, Zheng-Tao Lin, Han-Ying Lin, Bin Liu, Zhen-Wei Chen, Xin-Hua Ma, Yong-Hong Zhang

    Phytochemical investigations of Melia azedarach fruits have led to the isolation of a novel tirucallane triterpenoid (1), four new limonoids (2–5), and four known limonoids (6–9). Their structures were clarified by comprehensive spectroscopic and spectrometric analyses. The anti-inflammatory activities of isolated compounds were assessed in vitro. Compound 2 exhibited the most potent anti-inflammatory effect, with an IC50 value of 22.04 μM. Additionally, compound 2 attenuated LPS-induced reactive oxygen species (ROS) production and reduced the levels of inflammatory mediators IL-6 and TNF-α. A mechanistic study revealed that limonoid 2 suppresses the expression of iNOS and JAK2 and is implicated in the modulation of the NF-κB signaling cascade, which reveals its anti-inflammatory actions.